Amylin receptor drugs for Obesity

7 tracked Amylin receptor drugs in the Obesity race. The class explanation lives on the Amylin receptor page; the full indication pipeline across every mechanism is on the Obesity page.

5 Phase 31 Phase 21 Phase 1/2

Head-to-head evidence: ABBV-295 vs Lenbelintide · ABBV-295 vs MET-233i · ABBV-295 vs cagrilintide · ABBV-295 vs cagrilintide/semaglutide · ABBV-295 vs eloralintide · ABBV-295 vs petrelintide

The roster

← all Amylin receptor drugs